AQP1 and breast cancer: 41.9% (143/341) of IDC, 28.9% (13/45) of DCIS and 15.2% (5/33) of benign breast lesions showed high cytoplasmic expression of AQP1, indicating that cytoplasmic AQP1 probably be involved in breast cancer progression (Table 1).